Graf Acquisition Corp. IV (GFOR) is a Blank Checks company listed on NYSE. There were no new wire items for GFOR in the last 30 days. The most recent was published Feb 15, 2024.
Latest news
25 items- INSIDERSEC Form 4 filed by Scott Kathleen D.4 - NKGen Biotech, Inc. (0001845459) (Issuer)
- INSIDERSEC Form 4 filed by Kim Yong Man4 - NKGen Biotech, Inc. (0001845459) (Issuer)
- INSIDERSEC Form 4 filed by Song Paul Y.4 - NKGen Biotech, Inc. (0001845459) (Issuer)
- INSIDERSEC Form 4 filed by Gagnon Pierre4 - NKGen Biotech, Inc. (0001845459) (Issuer)
- INSIDERSEC Form 4 filed by Klowden Michael4 - NKGen Biotech, Inc. (0001845459) (Issuer)
- 13D/GSEC Form SC 13G filed by Graf Acquisition Corp. IVSC 13G - NKGen Biotech, Inc. (0001845459) (Subject)
- 13D/GSEC Form SC 13G/A filed by Graf Acquisition Corp. IV (Amendment)SC 13G/A - NKGen Biotech, Inc. (0001845459) (Subject)
- SECGraf Acquisition Corp. IV filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - NKGen Biotech, Inc. (0001845459) (Filer)
- SECGraf Acquisition Corp. IV filed SEC Form 8-K: Leadership Update8-K - NKGen Biotech, Inc. (0001845459) (Filer)
- 13D/GSEC Form SC 13G/A filed by Graf Acquisition Corp. IV (Amendment)SC 13G/A - NKGen Biotech, Inc. (0001845459) (Subject)
- SECGraf Acquisition Corp. IV filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - NKGen Biotech, Inc. (0001845459) (Filer)
- SECGraf Acquisition Corp. IV filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - NKGen Biotech, Inc. (0001845459) (Filer)
- SECGraf Acquisition Corp. IV filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - NKGen Biotech, Inc. (0001845459) (Filer)
- SECGraf Acquisition Corp. IV filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - NKGen Biotech, Inc. (0001845459) (Filer)
- SECGraf Acquisition Corp. IV filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - NKGen Biotech, Inc. (0001845459) (Filer)
- SECGraf Acquisition Corp. IV filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - NKGen Biotech, Inc. (0001845459) (Filer)
- 13D/GSEC Form SC 13D/A filed by Graf Acquisition Corp. IV (Amendment)SC 13D/A - NKGen Biotech, Inc. (0001845459) (Subject)
- INSIDERPark Sangwoo gifted 2,500,000 shares (SEC Form 4)4 - NKGen Biotech, Inc. (0001845459) (Issuer)
- SECSEC Form S-1/A filed by Graf Acquisition Corp. IV (Amendment)S-1/A - NKGen Biotech, Inc. (0001845459) (Filer)
- INSIDERSong Paul Y. bought $500 worth of shares (151 units at $3.30), increasing direct ownership by 0.09% to 171,121 units (SEC Form 4)4 - NKGen Biotech, Inc. (0001845459) (Issuer)
- INSIDERSong Paul Y. bought $850 worth of shares (268 units at $3.17), increasing direct ownership by 0.16% to 170,969 units (SEC Form 4)4 - NKGen Biotech, Inc. (0001845459) (Issuer)
- INSIDERGraf James A bought $2,172 worth of shares (670 units at $3.24), increasing direct ownership by 2,913% to 693 units (SEC Form 4)4 - NKGen Biotech, Inc. (0001845459) (Issuer)
- SECSEC Form S-1/A filed by Graf Acquisition Corp. IV (Amendment)S-1/A - NKGen Biotech, Inc. (0001845459) (Filer)
- INSIDERSong Paul Y. bought $701 worth of shares (244 units at $2.88), increasing direct ownership by 0.14% to 170,701 units (SEC Form 4)4 - NKGen Biotech, Inc. (0001845459) (Issuer)
- INSIDERGraf James A bought $67 worth of shares (23 units at $2.93) (SEC Form 4)4 - NKGen Biotech, Inc. (0001845459) (Issuer)
GFOR FAQ
7 questionsWhat does Graf Acquisition Corp. IV do?
Graf Acquisition Corp. IV focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2021 and is based in The Woodlands, Texas.What is the latest news on GFOR?
Quantisnow has not tracked any new filings, ratings or press releases for GFOR in the last 30 days. The most recent wire item was published on February 15, 2024.Where does GFOR stock trade?
Graf Acquisition Corp. IV (GFOR) is listed on NYSE.What sector and industry is GFOR in?
Graf Acquisition Corp. IV operates in the Finance sector, Blank Checks industry.When did Graf Acquisition Corp. IV go public?
Graf Acquisition Corp. IV (GFOR) completed its IPO in 2021.What companies are similar to GFOR?
Notable peers in the same industry include PRE (Prenetics Global Limited), OXSQ (Oxford Square Capital Corp.), INV (Innventure Inc.), ILLU (Illumination Acquisition Corp I), TACO (Berto Acquisition Corp.). Compare GFOR side-by-side with any of them on Quantisnow.How can I track GFOR on Quantisnow?
Quantisnow aggregates Graf Acquisition Corp. IV's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow GFOR to receive live email and push alerts on every new disclosure.